Product Information
ETONOGESTREL-EE VAGINAL RING is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $46.3541 per EA under NDC 00093767902. Its NADAC has been published 294 times since Feb 17, 2021.
FDA first approved this application on Jan 13, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.015; .12 mg/d; mg/d
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093767902
Classification
Generic
Dosage Form
INSERT, EXTENDED RELEASE
Route
VAGINAL
Effective Date
9/23/2026
Active Ingredients
ETHINYL ESTRADIOL; ETONOGESTRELApproval Type
Generic (ANDA)
FDA Application
ANDA204305FDA Approved
1/13/2021
TE Code
AB
On Market Since
1/19/2021
Price Statistics
The NADAC for ETONOGESTREL-EE VAGINAL RING has been published 294 times since Feb 17, 2021, and over the history we have for it it has declined 58.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $46.3541 per EA |
|---|---|
| All-time high | $112.6826 (Mar 10, 2021) |
| All-time low | $42.5371 (Nov 20, 2024) |
| 52-week high | $50.5133 |
| 52-week low | $46.3541 |
| Median price | $73.3595 |
| Average price | $72.6252 |
| Largest weekly change | +30.7% (Aug 21, 2024) |
| Weeks tracked | 294 |
| Tracking since | Feb 17, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Etonogestrel and Ethinyl Estradiol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Etonogestrel and Ethinyl Estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Estrogen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ETONOGESTREL-EE VAGINAL RING?
The current National Average Drug Acquisition Cost (NADAC) for ETONOGESTREL-EE VAGINAL RING, manufactured by Teva Pharmaceuticals USA Inc., is $46.3541 per EA (NDC 00093767902), effective Sep 30, 2026.
How has the price of ETONOGESTREL-EE VAGINAL RING changed over time?
Over the history we have for it, the NADAC for ETONOGESTREL-EE VAGINAL RING has declined 58.9%. It has been tracked across 294 weekly CMS publications since Feb 17, 2021.
What are the highest and lowest recorded NADAC prices for ETONOGESTREL-EE VAGINAL RING?
Since Feb 17, 2021, the NADAC for ETONOGESTREL-EE VAGINAL RING has ranged from a low of $42.5371 (Nov 20, 2024) to a high of $112.6826 (Mar 10, 2021), with a median of $73.3595 per EA.
Are there cheaper alternatives to ETONOGESTREL-EE VAGINAL RING?
No other NADAC-published product currently shares the active ingredient and strength of ETONOGESTREL-EE VAGINAL RING in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ETONOGESTREL-EE VAGINAL RING?
ETONOGESTREL-EE VAGINAL RING (NDC 00093767902) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.